Haemonetics | HAE - Cost Of Sales

Stock Price
59.34
Daily Change
-5.68 -8.74%
Monthly
-28.51%
Yearly
0%
Q1 Forecast
64.61

Haemonetics reported $136.58M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Avanos Medical USD 91.8M 8.9M Sep/2025
Baxter International USD 1.88B 66M Sep/2025
Becton, Dickinson and Co. USD 5.19B 2.32B Sep/2025
Boston Scientific USD 1.84B 82M Dec/2025
Cooper Companies USD 464.2M 45.9M Sep/2025
Fresenius EUR 4.19B 62M Sep/2025
Fresenius Medical Care EUR 3.64B 65.63M Sep/2025
Globus Medical USD 282.38M 3.42M Sep/2025
Haemonetics USD 136.58M 4.01M Dec/2025
Hologic USD 463.7M 5.1M Dec/2025
ICU Medical USD 336.11M 4.69M Sep/2025
Intuitive Surgical USD 961.9M 119.2M Dec/2025
Masimo USD 140.9M 3.3M Sep/2025
Medtronic USD 3.52B 80M Sep/2025
Merit Medical Systems USD 197.75M 229K Sep/2025
Neogen USD 118.01M 3.79M Sep/2025
Quidel USD -756.9M 1.14B Sep/2025
ResMed USD 555.85M 29.13M Dec/2025
STAAR Surgical USD 16.86M 5.34M Sep/2025
Steris USD 840.7M 26.3M Dec/2025
Stryker USD 2.69B 373M Dec/2025
Teleflex USD 461.38M 111.57M Sep/2025
Terumo JPY 127.97B 13.47B Sep/2025
Thermo Fisher Scientific USD 7.58B 674M Dec/2025
US Physical Therapy USD 158.23M 4.57M Sep/2025
Zimmer Biomet Holdings USD 735.8M 17M Sep/2025